Navigating Wegovy Dosing: What Is the Highest Approved Strength and What’s Next?

Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, reaches a maximum approved weekly dose of 2.4 milligrams for chronic weight management in adults with obesity or overweight with weight-related conditions. Understanding how this dose ladder works and whether it matches your body's needs requires looking beyond the highest strength available.

Understanding Semaglutide's Maximum Approved Dose Strength

The FDA approved semaglutide for weight loss at a top dose of 2.4 mg injected once weekly. This maximum strength represents the result of a 16-week titration schedule that begins at 0.25 mg and increases every four weeks. Patients typically reach the 2.4 mg strength by week 16 if tolerated well, though some individuals benefit from remaining at lower doses long-term.

Clinical trials demonstrated that 2.4 mg weekly produced significant weight reduction compared to placebo and lower doses. In the STEP 1 trial, adults receiving 2.4 mg semaglutide lost approximately 15% of their starting body weight over 68 weeks. However, reaching the highest strength isn't mandatory for meaningful results, and individual responses vary considerably based on genetics, metabolism, and gastrointestinal tolerance.

How Semaglutide Dosing Works: The Escalation Strategy

Semaglutide dosing follows a gradual titration plan designed to minimize nausea and other side effects while allowing your body to adapt. Starting at 0.25 mg weekly, the dose increases by 0.25 mg every four weeks until reaching 2.4 mg or until you and your provider decide a lower maintenance dose is optimal. This structured approach helps distinguish between temporary adjustment effects and true intolerance.

Some patients experience excellent weight loss at 1.7 mg or 2.0 mg and choose not to escalate further, prioritizing tolerability and cost efficiency. Others tolerate the climb to 2.4 mg and achieve their target weight loss there. Neither approach is wrong—your ideal dose depends on your personal response, side effect profile, and weight loss goals rather than simply pursuing the highest available strength.

Beyond Maximum Dose: What PlexusDx Offers Next

Once you've explored semaglutide's approved dosing range, PlexusDx provides additional personalized options through compounded formulations and combination protocols. PlexusDx compounded semaglutide injection starts at $149 per month and eliminates the flat per-compound pricing trap—your dose can increase while your monthly cost stays flat. For patients who plateau or require stronger therapeutic effects, PlexusDx also offers tirzepatide, a dual GLP-1 and GIP receptor agonist, and GLP-Squared, a proprietary dual-compound injection.

The Precision Peptide Genetic Test ($99 add-on) identifies how your genes affect GLP1R signaling, GIPR sensitivity, appetite regulation, and metabolic efficiency across 14 biological pathways. This testing reveals whether you're a responder to semaglutide alone or a candidate for tirzepatide or combination therapy—moving beyond guesswork to precision medicine.

When to Consider Alternatives to Standard Semaglutide Dosing

If you've titrated through semaglutide's approved doses and experienced plateauing weight loss, worsening side effects, or insufficient results, your provider may recommend switching compounds or strategies. Tirzepatide targets both GLP-1 and GIP pathways, offering a different mechanism that works for patients who don't optimize on semaglutide alone. PlexusDx compounded tirzepatide injection begins at $249 per month, with no hidden per-dose fees as you advance your therapy.

Genetic factors influence whether you'll thrive on semaglutide monotherapy or benefit from dual-agonist approaches. The FTO rs9939609 variant, MC4R rs17782313 variant, and GLP1R rs6923761 variant each correlate with appetite signaling strength and metabolic response patterns. PlexusDx mapping of these pathways helps your provider make evidence-based decisions rather than defaulting to the highest available dose of one compound.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the highest semaglutide dose approved by the FDA?

The maximum FDA-approved semaglutide dose for weight loss is 2.4 mg injected once weekly. Dosing escalates every four weeks starting from 0.25 mg, and most patients reach 2.4 mg by week 16 if they tolerate the medication well throughout the titration schedule.

Do I have to reach the 2.4 mg dose to see weight loss results?

No. Many patients achieve significant weight loss at lower doses like 1.7 mg or 2.0 mg and choose to stay there for tolerability and cost reasons. Clinical trials show meaningful results across the dose range, and your ideal strength depends on your individual response, not the highest available option.

How much weight can I expect to lose on semaglutide?

In clinical trials, patients on 2.4 mg semaglutide lost approximately 15% of body weight over 68 weeks. Individual results vary widely, and weight loss depends on dose tolerance, adherence, lifestyle factors, and genetic predisposition to GLP-1 signaling.

What does PlexusDx compounded semaglutide cost, and is pricing based on dose?

PlexusDx compounded semaglutide injection starts at $149 per month—flat pricing regardless of your dose strength. Your dose may need to go up; your price won't. The medication comes from licensed 503A compounding pharmacies and is available in all 50 states with no insurance required.

What options exist if semaglutide alone isn't working?

PlexusDx offers compounded tirzepatide injection (starts at $249/mo), a dual GLP-1 and GIP agonist, plus GLP-Squared dual-compound therapy and the Precision Peptide Genetic Test to identify which mechanism fits your biology. Testing reveals genetic markers like GLP1R rs6923761 and GIPR rs1800437 that predict responsiveness.

Is PlexusDx semaglutide FDA-approved?

PlexusDx compounds semaglutide through licensed 503A compounding pharmacies; compounded medications are not FDA-approved but are legally produced under federal pharmacy regulations. Semaglutide itself is FDA-approved in brand form (Wegovy) for chronic weight management.

Related Reading

• Wegovy Strength
• Ro Wegovy
• Mochi Wegovy
• Noom Wegovy

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.